These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7693985)

  • 41. Magnetic resonance imaging of the prostate gland.
    Schnall MD; Pollack HM
    Urol Radiol; 1990; 12(2):109-14. PubMed ID: 1700526
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An immunohistologic characterization of human prostatic atypical hyperplasia.
    Chou P; Ray V; Shaw M; Rubenstein M; Guinan P
    Urol Res; 1990; 18(3):193-6. PubMed ID: 1697711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ghrelin receptor as a novel imaging target for prostatic neoplasms.
    Lu C; McFarland MS; Nesbitt RL; Williams AK; Chan S; Gomez-Lemus J; Autran-Gomez AM; Al-Zahrani A; Chin JL; Izawa JI; Luyt LG; Lewis JD
    Prostate; 2012 Jun; 72(8):825-33. PubMed ID: 21919027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prostatic carcinoma and benign hypertrophy. Magnetic resonance aspects].
    Gevenois PA; Van Regemorter G; Van Sinoy ML; Diaz A; Struyven J
    Acta Urol Belg; 1986; 54(3):294-303. PubMed ID: 2430434
    [No Abstract]   [Full Text] [Related]  

  • 45. Prostatic intraepithelial neoplasia: a lesion that may be confused with cancer on prostatic ultrasound.
    Brawer MK; Rennels MA; Nagle RB; Soiderer MH; Lee F
    J Urol; 1989 Dec; 142(6):1510-2. PubMed ID: 2479777
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Anatomy and sonography of the prostate].
    Hammerer P; Huland H
    Urologe A; 1989 Nov; 28(6):311-6. PubMed ID: 2481356
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostatic carcinoma and benign prostatic hyperplasia: MR imaging with histopathologic correlation.
    Kahn T; Bürrig K; Schmitz-Dräger B; Lewin JS; Fürst G; Mödder U
    Radiology; 1989 Dec; 173(3):847-51. PubMed ID: 2479050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Magnetic resonance imaging of the prostate.
    Poon PY; McCallum RW; Henkelman MM; Bronskill MJ; Sutcliffe SB; Jewett MA; Rider WD; Bruce AW
    Radiology; 1985 Jan; 154(1):143-9. PubMed ID: 2578070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Usefulness of PSA density (PSAD) in the differential diagnosis between prostatic adenocarcinoma and benign ++ prostatic hypertrophy].
    Tiranti D; Annoscia S; Montefiore F; Boccafoschi C
    Arch Ital Urol Androl; 1994 Sep; 66(4 Suppl):59-63. PubMed ID: 7534168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 31P spectroscopy of the human prostate gland in vivo using a transrectal probe.
    Kurhanewicz J; Thomas A; Jajodia P; Weiner MW; James TL; Vigneron DB; Narayan P
    Magn Reson Med; 1991 Dec; 22(2):404-13. PubMed ID: 1725918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio.
    Kaynar M; Yildirim ME; Gul M; Kilic O; Ceylan K; Goktas S
    Cancer Biomark; 2015; 15(3):317-23. PubMed ID: 25586096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Magnetic resonance imaging of the prostate.
    Bryan PJ; Butler HE; Nelson AD; LiPuma JP; Kopiwoda SY; Resnick MI; Cohen AM; Haaga JR
    AJR Am J Roentgenol; 1986 Mar; 146(3):543-8. PubMed ID: 2418665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI.
    Liney GP; Turnbull LW; Lowry M; Turnbull LS; Knowles AJ; Horsman A
    Magn Reson Imaging; 1997; 15(10):1177-86. PubMed ID: 9408138
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Occult cancer in patients with symptomatic benign prostatic hyperplasia].
    Rodríguez Duarte C; Aguillón J; Rodríguez H
    Arch Esp Urol; 1991 May; 44(4):411-4. PubMed ID: 1712190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytokeratin 8/18 levels in patients with prostate cancer and benign prostatic hyperplasia.
    Wolff JM; Borchers H; Brehmer B; Brauers A; Jakse G
    Urol Int; 1998; 60(3):152-5. PubMed ID: 9644784
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nuclear magnetic resonance (NMR) imaging of the prostate.
    Steyn JH; Smith FW
    Br J Urol; 1984 Dec; 56(6):679-81. PubMed ID: 6085479
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Benign mimics of prostatic adenocarcinoma on needle biopsy.
    Gaudin PB; Reuter VE
    Anat Pathol; 1997; 2():111-34. PubMed ID: 9575372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nuclear magnetic resonance imaging of the prostate.
    Steyn JH; Smith FW
    Br J Urol; 1982 Dec; 54(6):726-8. PubMed ID: 6185173
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of prostate size: a comparison of ultrasound and magnetic resonance imaging.
    Hricak H; Jeffrey RB; Dooms GC; Tanagho EA
    Urol Radiol; 1987; 9(1):1-8. PubMed ID: 2440168
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings.
    Schiebler ML; Tomaszewski JE; Bezzi M; Pollack HM; Kressel HY; Cohen EK; Altman HG; Gefter WB; Wein AJ; Axel L
    Radiology; 1989 Jul; 172(1):131-7. PubMed ID: 2472644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.